Actavis plc (NYSE: ACT) today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and ...
Tags: Actavis, Warner Chilcott Company LLC, Abbreviated New Drug Application
Today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Ethinyl Estradiol and Etonogestrel Vaginal ...
Warner Chilcott has announced US FDA approval of norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate tablets, new oral contraceptive. The company expects to make the product available in early August 2013. ...
The US Food and Drug Administration (FDA) has approved Warner Chilcott's new oral contraceptive MINASTRIN 24 FE. MINASTRIN 24 FE (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) is indicated for use by ...
The US FDA has approved Warner Chilcott's 400mg mesalamine product as new ulcerative colitis therapy, to be marketed as Delzicol. Warner expects to commercially launch Delzicol in March 2013. Delzicol delayed-release capsules are ...
Mylan Pharmaceuticals has unveiled Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150mg, a generic version of Mayne Pharma's Doryx 150mg product. The company begins the shipment of the product. Mayne Pharma's Doryx 150mg product ...
Tags: Generic Doryx Tablets, tetracycline-class antimicrobial
Watson Pharmaceuticals has confirmed the filing of ANDA with FDA by Watson Laboratories seeking approval to market Norethindrone Acetate/Ethinyl Estradiol and Ethinyl Estradiol and Ferrous Fumarate Tablets, 1mg/0.01mg and 0.01mg and 75mg. ...
Tags: pharmaceutical product, pregnancy prevention drug, FDA